Citadel Advisors’s NorthView Acquisition Corporation Rights NVACR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-10,043
Closed -$1K 15587
2022
Q3
$1K Buy
+10,043
New +$970 ﹤0.01% 12444
2022
Q2
Sell
-35,175
Closed -$5K 14356
2022
Q1
$5K Buy
+35,175
New +$5.92K ﹤0.01% 13427

Other funds holding NVACR

Citadel Advisors's NVACR Position: Q4 2022 in Review

Citadel Advisors sold out of NorthView Acquisition Corporation Rights (NVACR) in Q4 2022, closing a stake of 10,043 shares — an estimated $1K sold.

Citadel Advisors first reported a position in NVACR in Q1 2022 and held it in 2 quarters. The position peaked at $5K in Q1 2022. 34 funds tracked by Wall St. Rank hold NVACR as of Q4 2022.

  • Citadel Advisors reported no remaining NorthView Acquisition Corporation Rights position as of Q4 2022 after selling out during the quarter.
  • Citadel Advisors sold 10,043 NorthView Acquisition Corporation Rights shares in Q4 2022, an estimated $1K.
  • Citadel Advisors first reported a position in NorthView Acquisition Corporation Rights in Q1 2022 and held it in 2 quarters.
  • Citadel Advisors's NorthView Acquisition Corporation Rights position peaked at $5K in Q1 2022.
  • 34 funds tracked by Wall St. Rank held NorthView Acquisition Corporation Rights as of Q4 2022.

Based on Citadel Advisors's 13F filing for Q4 2022, filed 14 Feb 2023.